{"entity":{"type":"insider","cik":"0001721664","url":"/insider/0001721664","json_url":"/insider/0001721664.json","name":"Laumas Sandeep","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":10,"first":"2018-08-28","last":"2025-09-12","span_basis":"filed_date"},"name_variants":[{"name":"Laumas Sandeep","source":"filing","n_filings":10,"first_seen":"2018-08-28","last_seen":"2025-09-12"}],"transactions":[{"id":4854843,"accession":"0001789769-25-000087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001789769-25-000087","line_url":"/filing/0001789769-25-000087","is_derivative":false,"issuer_cik":"0001721664","issuer_name":"Instil Bio, Inc.","issuer_ticker":"TIL","issuer_name_source":null,"issuer_url":"/issuer/0001721664","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":23.388908,"price_display":"23.39","price_state":"stated","total_value":701667.24,"total_display":"701,667.24","total_whole":"701,667","shares_owned_after":12461.0,"shares_owned_after_display":"12,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider","n_lines":2},{"id":7902580,"accession":"0001551986-19-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-19-000082","line_url":"/filing/0001551986-19-000082#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (CEO, Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":4600.0,"total_display":"4,600.00","total_whole":"4,600","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-07-01","scope":"insider"},{"id":8534188,"accession":"0001551986-19-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001551986-19-000077","line_url":"/filing/0001551986-19-000077","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (CEO, Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.21591,"price_display":"1.22","price_state":"stated","total_value":1215.91,"total_display":"1,215.91","total_whole":"1,216","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-17","scope":"insider","n_lines":2},{"id":7937526,"accession":"0001551986-19-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-19-000054","line_url":"/filing/0001551986-19-000054#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (CEO, Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":6900.0,"total_display":"6,900.00","total_whole":"6,900","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-23","scope":"insider"},{"id":6468423,"accession":"0001551986-18-000060","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001551986-18-000060","line_url":"/filing/0001551986-18-000060","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.63,"price_display":"2.63","price_state":"stated","total_value":7890.0,"total_display":"7,890.00","total_whole":"7,890","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider","n_lines":3},{"id":6841565,"accession":"0001551986-18-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001551986-18-000055","line_url":"/filing/0001551986-18-000055","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.5566666666666666,"price_display":"2.56","price_state":"stated","total_value":7670.0,"total_display":"7,670.00","total_whole":"7,670","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-29","scope":"insider","n_lines":2},{"id":6353819,"accession":"0001551986-18-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-18-000029","line_url":"/filing/0001551986-18-000029#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":3050.0,"total_display":"3,050.00","total_whole":"3,050","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-07","filed_date":"2018-09-10","scope":"insider"},{"id":6531893,"accession":"0001551986-18-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-18-000027","line_url":"/filing/0001551986-18-000027#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":2620.0,"total_display":"2,620.00","total_whole":"2,620","shares_owned_after":750.0,"shares_owned_after_display":"750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-30","filed_date":"2018-08-30","scope":"insider"},{"id":9291560,"accession":"0001551986-18-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-18-000025","line_url":"/filing/0001551986-18-000025#line-1","is_derivative":false,"issuer_cik":"0001721664","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001721664","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":1225.0,"total_display":"1,225.00","total_whole":"1,225","shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-30","scope":"insider"},{"id":6159891,"accession":"0001551986-18-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001551986-18-000020","line_url":"/filing/0001551986-18-000020#line-4","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":405.0,"shares_display":"405","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":2057.4,"total_display":"2,057.40","total_whole":"2,057","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-28","scope":"insider"},{"id":6159889,"accession":"0001551986-18-000020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001551986-18-000020","line_url":"/filing/0001551986-18-000020#line-3","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":4.88,"price_display":"4.88","price_state":"stated","total_value":1220.0,"total_display":"1,220.00","total_whole":"1,220","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-28","scope":"insider"},{"id":6159885,"accession":"0001551986-18-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001551986-18-000020","line_url":"/filing/0001551986-18-000020#line-2","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":95.0,"shares_display":"95","price_per_share":5.07,"price_display":"5.07","price_state":"stated","total_value":481.65,"total_display":"481.65","total_whole":"482","shares_owned_after":595.0,"shares_owned_after_display":"595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-28","scope":"insider"},{"id":6159878,"accession":"0001551986-18-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001551986-18-000020","line_url":"/filing/0001551986-18-000020#line-1","is_derivative":false,"issuer_cik":"0001551986","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001551986","owner_cik":"0001721664","owner_name":"Laumas Sandeep","owner_display_name":"Laumas Sandeep","owner_url":"/insider/0001721664","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":250.0,"shares_owned_after_display":"250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-28","filed_date":"2018-08-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789769","name":"Instil Bio, Inc.","url":"/issuer/0001789769","role":"Officer (CFO and CBO)","n_filings":1,"first_seen":"2025-09-12","last_seen":"2025-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001551986","name":"INNOVATE BIOPHARMACEUTICALS, INC.","url":"/issuer/0001551986","role":"Director, Officer (CEO, Executive Chairman)","n_filings":9,"first_seen":"2018-08-28","last_seen":"2019-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001721664","retrieved_at":"2026-08-22T10:38:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}